A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis
Yusei Miyazaki(National Hospital Organization Hokkaido Medical Center), Amit Bar‐Or(University of Pennsylvania), David Colman(Montreal Neurological Institute and Hospital), Mayra Solis(Montreal Neurological Institute and Hospital), Craig S. Moore(Memorial University of Newfoundland), Jennifer L. Gommerman(University of Toronto), Ajit Singh Dhaunchak(Montreal Neurological Institute and Hospital), Simon Fillatreau(Hôpital Necker-Enfants Malades), Jack P. Antel(Montreal Neurological Institute and Hospital), Hétoum Misirliyan(Montreal Neurological Institute and Hospital), Alexandre Prat(Université de Montréal), Ayman Rezk(Montreal Neurological Institute and Hospital), Lorna Galleguillos(Montreal Neurological Institute and Hospital), Rui Li(Max Planck Institute of Immunobiology and Epigenetics), Nasr Farooqi(Montreal Neurological Institute and Hospital), Omar de Faria(Montreal Neurological Institute and Hospital), Van Duc Dang(German Rheumatism Research Centre)
Cited by 91
Related Papers
The Blood–Brain Barrier
|Cold Spring Harbor Perspectives in Biology|2015|3.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
|Nature Medicine|2007|1.8k
B cells regulate autoimmunity by provision of IL-10
|Nature Immunology|2002|1.6k